Life Sciences

Cukierman & Co. Life Sciences (CLS) provides services to companies across the Life Sciences spectrum including biotechnology, pharmaceuticals, medical devices and e-health technologies.

Established in 2006 as the Life Sciences Corporate Finance arm of Cukierman & Co, CLS offers investment banking services to private and public companies at different stages of their development cycle. CLS has been engaged in an increasing number of successful Private Placements and more recently IPOs, in Europe, US and China.

Our mission :

  • Assisting life sciences companies in identifying, negotiating and closing equity and debt financings, licensing agreements, strategic partnerships, M&A transactions.
  • Supporting investors and funds in selecting, evaluating, acquiring and divesting assets, businesses and companies in all life sciences sectors.

Our extensive international industry relationships as well as our finance, business and scientific background, generate creative ideas and sound solutions for the demands that characterize the life sciences industry.


Global access to capital and financing is critical for our clients and counterparties who are looking for efficient private placement, M&A and licensing transactions.

Our offices and integrated networks throughout multiple geographies allows us to access over 2500 investors.
Deal evaluation includes analysis of corporate management, corporate finance, assessment of underlying scientific medical principles, clinical applications, clinical study design, drug and device approval feasibility, intellectual property, commercial application, pricing, reimbursement and analysis of regulatory, legal, and economic changes that affect market dynamics and competitive landscape.


  • Private Placements
  • IPO
  • PIPE
  • M&A financing

Mergers and acquisitions

  • Sell side
  • Buy side
  • Reverse mergers
  • Divestitures

Access to key industry players

Our senior management team and industry networks bring together sector expertise, investment experience, and regulatory, scientific and medical knowledge to emerging healthcare and life science companies, funds and private equity firms.

In recent years, Israel has been at the forefront of bringing major Life Sciences innovations to the market. We offer international groups and VCs access to the Israeli market, helping them to identify and qualify partnerships, investments or acquisition.

  • Strategic R&D partnership
  • In- and out-licensing
  • Asset acquisition and sales
  • Deal strategy, structuring & negotiation
  • Transaction management

related fields of expertise:

  • Company set-up, restructuring and governance
  • Technology, R&D, Patent and Portfolio analysis
  • Regulatory Affairs Strategy and Compliance Services Save
  • Reimbursement and Pricing Services
  • Clinical Research and Clinical Trial Services
  • Licensing, Strategic Partnerships, and Marketing
  • Company valuation modeling and fairness opinion
  • Business plan

Access to our Intelligence Solutions in Life Sciences in partnership with 

Signals provides decision-support solutions based on insights generated from big data on the web using intelligence methodologies and business analytics models to help you make better, faster decisions. Our insights are determined by the best of man and machine: superior automated technology for collection and analysis, and teams of intelligence analysts and subject matter experts.


We provide end-to-end decision support for the product life cycle. Our mission is to be the most trusted partner to the world’s leading companies in providing the highest-quality decision support for our clients’ new product development, product introduction, innovation initiatives, competitive and market intelligence, and exploration of new spaces for growth.


How do we work ?

Based on your mission. As former intelligence officers, we see every one of your business missions as many intelligence questions to be answered, which we solve through our advanced automated search, data collection, and analysis.


Big Data Collection

We cast a wide net for big data to give you the most complete intelligence available. Our sourcing experts identify the best places to uncover the information we need to answer your intelligence questions, from patent listings to trademark databases to the archives of major trade publications; from the websites of your competitors to the social media where your customers chatter about your products. As we work, we focus on being comprehensive, relevant, accurate and timely, to give you the most detailed picture possible of the information you need, on time.


Intelligence Methodologies

Have we mentioned that we are former military intelligence officers and are sticklers for methodology? Traditional intelligence methods guide our work: we believe in looking at information from many different angles.


Analytic Models

We use a mix of traditional and proprietary models for analysis.


Ongoing Support

Signals is your intelligence partner. Our business missions are designed to give you the insights you need to act today and set you up to continue to consume intelligence in an actionable way. This is why Monitoring and Always-On Alerting are key components to so many of our missions – the benefits of intelligence build on one another as you receive real-time updates on all the most significant players in your ecosystem.


Current Clients

Illustration of International Life Sciences Clients

Selected Transactions



EVENT 2017

Sachs Forum, MARCH 6-7th 2017, Zurich, Switzerland
Cukierman & Co Life Sciences partner of the Sachs Forum, Dr. Emmanuel Elalouf panelist at Seed Companies Investor Roundtable
Braintech, March 6-7th 2017, Tel-Aviv, Israel
Dr. Laurent Choppe panelist at Investments in BrainTech

EVENT 2016

SACHS Associates, 27th - 28th SEPTEMBER 2016, Zurich, Switzerland
EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION for Partnering and Investing in Biotech & Pharma Industry
Tech Tour Healthtech Summit, June 21st - 22nd 2016, Lausanne, Switzerland
Cukierman & Co. Life Sciences partner of the TechTour HealthTech Summit, Dr. Laurent Choppe panelist.
SACHS Associates,15th -16th MARCH 2016, Zurich, Switzerland
EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION for Partnering and Investing in Biotech & Pharma Industry


■ Baxter : Ventures invests in Medasense Biometrics
May 23, 2016
■ Israeli Health Tech Is Heating Up With A Wave Of Interest From Abroad
October 25, 2015
■ Interview I24 Dr Laurent Choppe Go4Israel conference
October 17, 2015
■ Chinese investments - the new financing source for Israeli Life Science industry
October 17, 2015
■ Israel Valley article on Green Onyx
February 21, 2015
■ Globes article on Check-Cap IPO
February 19, 2015
■ Xeltis on its fund raising
January, 2015
■ Opsona therapeutics on its fund raising
January, 2015